POCI COO granted 60,000 stock options at $4.34 exercise price
Precision Optics Corporation (POCI) disclosed a Form 4 showing an inducement stock option grant to its Chief Operating Officer.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Precision Optics Corporation (POCI) disclosed a Form 4 showing an inducement stock option grant to its Chief Operating Officer. On October 1, 2025, the executive received options to purchase 60,000 shares of common stock at an exercise price of $4.34 per share.
The option vests in three equal annual installments beginning October 1, 2026, and expires on October 1, 2035. Following the grant, the reporting person beneficially owns 60,000 derivative securities, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Rights to buy) | 60,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. On October 1, 2025, the Reporting Person was granted an inducment stock option to purchase 60,000 shares of Issuer's common stock that vests in three equal annual installments beginning on October 1, 2026. The inducment stock option is subject to a Stock Option Agreement by and between the Reporting Person and the Issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did POCI report in this Form 4 filing?
When do the POCI options vest and expire?
What is the exercise price for the options reported by POCI?
How many derivative securities does the reporting person own after the transaction?
What is the purpose of the option grant disclosed by POCI?
Is the ownership direct or indirect for the reported POCI options?
AI-generated analysis. How Rhea-AI works. Not financial advice.